James B. Hoffman
United States Military Academy
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James B. Hoffman.
Bioorganic & Medicinal Chemistry Letters | 2001
Kenneth J. Wilson; Carl R. Illig; Nalin Subasinghe; James B. Hoffman; M. Jonathan Rudolph; Richard Soll; Christopher J. Molloy; Roger F. Bone; David W. Green; Troy Randall; Marie Zhang; Frank Lewandowski; Zhao Zhou; Celia Sharp; Diane Maguire; Bruce L. Grasberger; Renee L. DesJarlais; John Spurlino
The serine protease urokinase (uPa) has been implicated in the progression of both breast and prostate cancer. Utilizing structure based design, the synthesis of a series of substituted 4-[2-amino-1,3-thiazolyl]-thiophene-2-carboxamidines is described. Further optimization of this series by substitution of the terminal amine yielded urokinase inhibitors with excellent activities.
Bioorganic & Medicinal Chemistry Letters | 2002
M. Jonathan Rudolph; Carl R. Illig; Nalin Subasinghe; Kenneth J. Wilson; James B. Hoffman; Troy L. Randle; David W. Green; Chris Molloy; Richard Soll; Frank Lewandowski; Marie Zhang; Roger F. Bone; John Spurlino; Ingrid Deckman; Carl L. Manthey; Celia Sharp; Diane Maguire; Bruce L. Grasberger; Renee L. DesJarlais; Zhao Zhou
A study of the S1 binding of lead 5-methylthiothiophene amidine 3, an inhibitor of urokinase-type plasminogen activator, was undertaken by the introduction of a variety of substituents at the thiophene 5-position. The 5-alkyl substituted and unsubstituted thiophenes were prepared using organolithium chemistry. Heteroatom substituents were introduced at the 5-position using a novel displacement reaction of 5-methylsulfonylthiophenes and the corresponding oxygen or sulfur anions. Small alkyl group substitution at the 5-position provided inhibitors equipotent with but possessing improved solubility.
Bioorganic & Medicinal Chemistry Letters | 2001
Nalin Subasinghe; Carl R. Illig; James B. Hoffman; M. Jonathan Rudolph; Kenneth J. Wilson; Richard Soll; Troy L. Randle; David W. Green; Frank Lewandowski; Marie Zhang; Roger F. Bone; John Spurlino; Renee L. DesJarlais; Ingrid Deckman; Christopher J. Molloy; Carl L. Manthey; Zhau Zhou; Celia Sharp; Diane Maguire; Carl Crysler; Bruce L. Grasberger
The serine protease urokinase plasminogen activator (uPA) is thought to play a central role in tumor metastasis and angiogenesis. Molecular modeling studies suggest that 5-thiomethylthiopheneamidine inhibits uPA by binding at the S1 pocket of the active site. Further structure based elaboration of this residue resulted in a novel class of potent and selective inhibitors of uPA.
Bioorganic & Medicinal Chemistry Letters | 1995
Doug W. Hobbs; Norman P. Gould; James B. Hoffman; Bradley V. Clineschmidt; Douglas J. Pettibone; Daniel F. Veber; Roger M. Freidinger
Abstract The structure activity relationships of a series of non-peptide oxytocin antagonists containing a camphor aminosuccinimide as a key structural element were investigated. A potent and selective analog was identified and prepared in diastereomerically pure form starting from aspartic acid.
Archive | 1999
Carl R. Illig; Nalin L. Subasinghe; James B. Hoffman; Kenneth J. Wilson; M. Jonathan Rudolph
Archive | 2001
Carl R. Illig; Nalin L. Subasinghe; James B. Hoffman; Kenneth J. Wilson; M. Jonathan Rudolph; Juan J. Marugan
Archive | 2001
Carl R. Illig; Nalin L. Subasinghe; James B. Hoffman; Kenneth J. Wilson; M. Jonathan Rudolph; Roger F. Bone; Scott L. Klein; Troy L. Randle
Archive | 2002
Carl R. Illig; Nalin L. Subasinghe; James B. Hoffman; Kenneth J. Wilson; M. Jonathan Rudolph; Juan J. Marugan
Archive | 2000
Carl R. Illig; Nalin L. Subasinghe; James B. Hoffman; Kenneth J. Wilson; M. Jonathan Rudolph; Roger F. Bone; Scott L. Klein; Troy L. Randle
Archive | 1999
Carl R. Illig; Nalin L. Subasinghe; James B. Hoffman; Kenneth J. Wilson; M. Jonathan Rudolph; Juan J. Marugan